Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial

Epco Hasker1, Younoussa Assoumani2, Andriamira Randrianantoandro3

  • 1Institute of Tropical Medicine, Antwerp, Belgium.

PubMed
Summary

Single-dose rifampicin post-exposure prophylaxis (SDDR-PEP) shows promise in reducing leprosy incidence, particularly when administered broadly. Targeted screening around infected individuals enhances its protective effect against Mycobacterium leprae transmission.